(Total Views: 332)
Posted On: 03/06/2023 1:10:47 PM
Post# of 151
$MRK News Article - Merck's Investigational Activin Signaling Inhibitor Sotatercept Improved Six-Minute Walk Distance by 40.8 Meters at Week 24 Versus Placebo in Adults with Pulmonary Arterial Hypertension on Background Therapy https://marketwirenews.com/news-releases/merc...34928.html
(0)
(0)
My Twitter: WhyteStocks
